Explore / Peer-reviewed article
Peer-reviewed articleOpen access

Merits and demerits of administering esketamine in preventing postpartum depression following cesarean section.

Nagamine TiD

World journal of clinical casesDec 1, 2024License: open accessJapan0 citationsDOI: 10.12998/wjcc.v12.i36.6883

Abstract

Emergency cesarean section is associated with the development of postpartum depression. Esketamine has been demonstrated to have a rapid onset of antidepressant effects. Randomized controlled trials and meta-analyses have demonstrated the efficacy of esketamine in preventing postpartum depression after cessarean section. However, the data included in these analyses were derived from elective cesarean sections and differed in the dose and timing of esketamine administration. Esketamine is a dissociative anesthetic with a dose-dependent risk of inducing psychotic symptoms, including hallucinations. In the setting of cesarean section, esketamine should be administered with caution and only if the potential benefits outweigh the risks.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

Cesarean sectionMedial Prefrontal CortexAdverse EventEsketamine

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.